Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients’ offspring

OBJECTIVES: To study pregnancy outcomes in a closely monitored, well-defined cohort of women with rheumatoid arthritis (RA). In particular, pregnancy outcomes of women that used a TNFi during pregnancy. METHODS: Patients were derived from a prospective study on pregnancy and RA (Preconception Counse...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeele, Hieronymus T W, Röder, Esther, Mulders, Annemarie G M G J, Steegers, Eric A P, Dolhain, Radboud J E M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484384/
https://www.ncbi.nlm.nih.gov/pubmed/35817469
http://dx.doi.org/10.1136/ard-2022-222679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484384/
https://www.ncbi.nlm.nih.gov/pubmed/35817469
http://dx.doi.org/10.1136/ard-2022-222679

Ejemplares similares